PPARGC1A and colorectal neoplasm: 1) Chemotherapy of colorectal tumor cells induces a SIRT1/PGC1a-dependent increase in oxidative phosphorylation that promotes tumor survival during treatment because chemotherapy induces a shift in tumor energy metabolism that protects tumor cells from cytotoxic damage [26].